Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

UPDATE: Mural Oncology Q2 Adj. EPS $(1.77) Misses $(1.34) Estimate

Author: Benzinga Newsdesk | August 04, 2025 07:43am
Mural Oncology (NASDAQ:MURA) reported quarterly losses of $(1.77) per share which missed the analyst consensus estimate of $(1.34) by 32.09 percent. This is a 4.84 percent increase over losses of $(1.86) per share from the same period last year.

Posted In: MURA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist